Quanterix Corporation
QUANTITATIVE ANTIBODY TEST

Last updated:

Abstract:

The present disclosure relates to methods and compositions, e.g., kits, for quantitatively detecting an antibody of a subject to an infectious organism. In some embodiments, the present disclosure provides for methods and compositions, e.g., kits, for quantitatively detecting a human antibody to SARS-CoV-2 polypeptide or S (spike) polypeptide. Certain applications and uses of the present methods and compositions, e.g., kits, are also provided.

Status:
Application
Type:

Utility

Filling date:

28 Apr 2021

Issue date:

4 Nov 2021